Key Drivers
- Strong FCF
- High leverage
- Compressed margins
AIAI Summary
HSIC is shifting from a commodity distributor toward a higher‑margin, SaaS‑and‑services platform—making it a potential re‑rate candidate—but that upside is execution‑dependent given material leverage and working‑capital sensitivity. Monitor multi‑quarter non‑GAAP operating margin improvement, FCF conversion without inventory/receivable swings, and debt reduction; failure on these fronts would likely trigger downside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •High leverage
- •Compressed margins
HSIC generates strong operating cash and positive free cash flow with healthy gross margins and double‑digit ROIC, but very high operating expenses and leverage compress net profitability and limit balance‑sheet flexibility.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Support being tested
- •Resistance cluster
HSIC is in a clear short-term downtrend over the last month, trading at $72.29 and testing near-term support around $72–75 with resistance clustered at $80–83, where a decisive break below $72 risks further downside while a reclaim of $80 would signal a rebound.
Large swings from late
Sentiment & News
Key News Insights:
- •Sales beat
- •Margin pressure
- •Strategic push
Henry Schein delivered a solid revenue beat with Q4 sales growth but margin compression and modest 2026 guidance temper upside despite strategic moves and investor interest.
Solid top-line momentum supports the stock, but margin headwinds and cautious guidance likely limit near-term upside until margin improvement is visible
Similar Companies in Healthcare
Other companies in the same sector with AI ratings